Pharmaceutical vending machine at an airport. Image by Tim Sandle. Pharmaceutical vending machine at an airport. Image by Tim Sandle. Can a new discovery usher in a new generation of GLP-1 peptides – ...
The glucagon-like peptide 1 (GLP-1) market is poised for growth due to rising diabetes and obesity rates, expanded therapy ...
Use of glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced risk of developing substance use disorders among US veterans with type 2 diabetes. Evidence Rating Level: 2 (Good) ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Glucagon-like peptide-1 agonists were not associated ...
As of 2021–2022, approximately 74% of U.S. adults aged 20 and older were classified as overweight or obese, with 42.1% meeting criteria for obesity alone, according to the Centers for Disease Control ...
MASLD is one of the pressing public health issues; yet, unfortunately, there is a scarcity of available pharmacological management options. GLP-1RAs have transformed the treatment landscape for ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients prescribed glucagon-like peptide-1 agonists had ...
Glucagon-like peptide-1 receptor agonists and incidence of obesity-related cancer in adults with diabetes: A target-trial emulation study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
The intricate interplay between pancreatic beta cells and glucagon-like peptide-1 (GLP-1) has drawn considerable attention in efforts to improve the diagnosis and treatment of diabetes and insulinomas ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when appropriately prescribed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results